Citation Impact
Citing Papers
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
2016
ERK activation and autophagy impairment are central mediators of irinotecan-induced steatohepatitis
2017
Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer
2021 StandoutNobel
Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review
2023 Standout
Breast cancer
2019 Standout
Breast-cancer detection using blood-based infrared molecular fingerprints
2021 StandoutNobel
Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy
2015
A view on drug resistance in cancer
2019 StandoutNature
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer
2017
Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape
2016
Integrating liquid biopsies into the management of cancer
2017
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
EMT Transition States during Tumor Progression and Metastasis
2018 Standout
Liquid Biopsies, What We Do Not Know (Yet)
2017
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Colorectal cancer
2019 Standout
Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis
2015
Multimodal biomedical AI
2022 Standout
Liquid biopsy
2015
Liquid biopsy in cancer patients: advances in capturing viable CTCs for functional studies using the EPISPOT assay
2015
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Epithelial-mesenchymal plasticity in circulating tumor cells
2016
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
EMT: 2016
2016 Standout
The biology of circulating tumor cells
2015
Circulating tumor cells and CDX models as a tool for preclinical drug development
2017
Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells
2019
Mitochondrial signal transduction
2022
Tumour heterogeneity and resistance to cancer therapies
2017 Standout
Biomarker-driven and molecular targeted therapies for colorectal cancers
2017
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment
2017
Epithelial–mesenchymal plasticity and circulating tumor cells: Travel companions to metastases
2017
Epithelial Mesenchymal Transition in Tumor Metastasis
2018 Standout
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
Works of Thibault Mazard being referenced
Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care
2016
Establishment and Characterization of a Cell Line from Human Circulating Colon Cancer Cells
2015
Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment
2015
Molecular Portrait of Metastasis-Competent Circulating Tumor Cells in Colon Cancer Reveals the Crucial Role of Genes Regulating Energy Metabolism and DNA Repair
2016
Sorafenib Overcomes Irinotecan Resistance in Colorectal Cancer by Inhibiting the ABCG2 Drug-Efflux Pump
2013
Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin
2016
Blood contains circulating cell‐free respiratory competent mitochondria
2020